Login
Register

Home
Bollywood
Slideshows
Entertainment
Fashion
Fashion Designers
Gossip
Health and Science
Lifestyle
Tech
Travel
About
Designer Swimwear 2010 - MBFW Miami
Tibi Swimwear
L*Space by Monica Wise
Shay Todd
Ed Hardy
Tibi
Cia.Marítima
Luli Fama
Caffe

Designer Swimwear 2009 - MBFW LA
Rosa Cha Swimwear
Ed Hardy by Christian Audigier
Caroline D'Amore
Beach Bunny

Designer Swimwear 2009 - MBFW Miami
Ed Hardy Swimwear
Ed Hardy by Christian Audigier
Pistol Panties
Gottex bikini
Rosa Cha
Ashley Paige
Beach Bunny

Loading
Home > Health
Previous Next
Steroid drug added to ongoing multiple sclerosis treatment reduces relapses
Posted on Thursday, April 30, 2009 (EST)
Using a steroid drug for multiple sclerosis (MS) in addition to an MS drug may reduces the amount of disease activity more than using the MS drug alone.
 
Print this page
Email this page

Using a steroid drug for multiple sclerosis (MS) in addition to an MS drug may reduces the amount of disease activity more than using the MS drug alone.
© AFP/File Torsten Blackwood

April 30, 2009, (Sawf News) - Using a steroid drug for multiple sclerosis (MS) in addition to an MS drug may reduces the amount of disease activity more than using the MS drug alone.

For the study, people with MS received the steroid drug methylprednisolone in monthly "pulses," or three doses over three days, in addition to regular weekly treatment with the drug interferon beta-1a. The steroid drug has typically been used only to treat acute MS attacks, not as an ongoing treatment.

The study involved 341 people with relapsing-remitting MS. Half of the participants received both drugs; half received only the interferon drug plus a placebo. The participants were seen every three months during the three-year study for evaluation.

The participants had the disease for an average of three years and had not yet received a disease-modifying drug such as interferon.

Those who received both drugs had 38 percent fewer relapses, or times when the disease is active, than those receiving only the interferon drug. They also improved slightly on a test of MS disability, while the scores for the placebo group decreased slightly.

At the beginning of the study and again after three years, the researchers measured the size of lesions in the brain that are a sign of disease activity. For those receiving both drugs, the lesions stayed the same size or shrunk, while the size of the lesions grew for those taking only interferon.

"These results indicate that these two drugs may have a synergy when taken together and provide a more beneficial effect on the disease activity," said study author Mads Ravnborg, MD, of the Danish Multiple Sclerosis Research Center at Copenhagen University Hospital in Denmark. "This is a promising finding, as the benefit from interferon is only moderate and not everyone responds fully to the treatment, so anything we can do to boost those results is positive."

News Copyright © Sawf News. May not be reproduced without explicit written permission

Related Topics:

  • Further evidence Tysabri improves quality of life of multiple sclerosis (MS) patients
  • High blood pressure drug for multiple sclerosis (MS) treatment
  • Smoking worsens multiple sclerosis (MS)
  • Healing Multiple Sclerosis (MS) with Whole Foods
  • Breastfeeding reduces relapse in women with multiple sclerosis
  • Add Your Comment



    Sawf News on mobile
    Section Headlines
    Health Topics
    Privacy